DMD c.2776_2777delinsGC ;(p.Q926A)

Variant ID: X-32503062-TG-GC

NM_004006.2(DMD):c.2776_2777delinsGC;(p.Q926A)

This variant was identified in 10 publications

View GRCh38 version.




Publications:


Translational potential of base-editing tools for gene therapy of monogenic diseases.

Frontiers In Bioengineering And Biotechnology
Reshetnikov, Vasiliy V VV; Chirinskaite, Angelina V AV; Sopova, Julia V JV; Ivanov, Roman A RA; Leonova, Elena I EI
Publication Date: 2022

Variant appearance in text: DMD: Q926A
PubMed Link: 36032737
Variant Present in the following documents:
  • Main text
  • fbioe-10-942440.pdf
View BVdb publication page



The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing.

Frontiers In Cell And Developmental Biology
Vicente, Manuel M MM; Chaves-Ferreira, Miguel M; Jorge, João M P JMP; Proença, João T JT; Barreto, Vasco M VM
Publication Date: 2021

Variant appearance in text: DMD: Q926A
PubMed Link: 34604217
Variant Present in the following documents:
  • Main text
  • fcell-09-718466.pdf
View BVdb publication page



Development of CRISPR technology for precise single-base genome editing: a brief review.

Bmb Reports
Lee, Hyomin K HK; Oh, Yeounsun Y; Hong, Juyoung J; Lee, Seung Hwan SH; Hur, Junho K JK
Publication Date: 2021-02

Variant appearance in text: DMD: Q926A
PubMed Link: 33298245
Variant Present in the following documents:
  • Main text
View BVdb publication page



CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.

Frontiers In Oncology
Uddin, Fathema F; Rudin, Charles M CM; Sen, Triparna T
Publication Date: 2020

Variant appearance in text: DMD: Q926A
PubMed Link: 32850447
Variant Present in the following documents:
  • Main text
  • fonc-10-01387.pdf
View BVdb publication page



Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing.

Journal Of Molecular Medicine (Berlin, Germany)
Han, Hua Alexander HA; Pang, Jeremy Kah Sheng JKS; Soh, Boon-Seng BS
Publication Date: 2020-05

Variant appearance in text: DMD: Q926A
PubMed Link: 32198625
Variant Present in the following documents:
  • Main text
  • 109_2020_Article_1893.pdf
View BVdb publication page



The next generation of CRISPR-Cas technologies and applications.

Nature Reviews. Molecular Cell Biology
Pickar-Oliver, Adrian A; Gersbach, Charles A CA
Publication Date: 2019-08

Variant appearance in text: DMD: Q926A
PubMed Link: 31147612
Variant Present in the following documents:
  • Main text
View BVdb publication page



DNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells.

Iscience
Chen, Xiaoyu X; Gonçalves, Manuel A F V MAFV
Publication Date: 2018-08-31

Variant appearance in text: DMD: Q926A
PubMed Link: 30240615
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



CRISPR/Cas9 Immune System as a Tool for Genome Engineering.

Archivum Immunologiae Et Therapiae Experimentalis
Hryhorowicz, Magdalena M; Lipiński, Daniel D; Zeyland, Joanna J; Słomski, Ryszard R
Publication Date: 2017-06

Variant appearance in text: DMD: Q926A
PubMed Link: 27699445
Variant Present in the following documents:
  • Main text
  • 5_2016_Article_427.pdf
View BVdb publication page



Probing the impact of chromatin conformation on genome editing tools.

Nucleic Acids Research
Chen, Xiaoyu X; Rinsma, Marrit M; Janssen, Josephine M JM; Liu, Jin J; Maggio, Ignazio I; Gonçalves, Manuel A F V MA
Publication Date: 2016-07-27

Variant appearance in text: DMD: Q926A
PubMed Link: 27280977
Variant Present in the following documents:
  • Main text
  • gkw524.pdf
View BVdb publication page



Genome Editing with CRISPR-Cas9: Can It Get Any Better?

Journal Of Genetics And Genomics = Yi Chuan Xue Bao
Haeussler, Maximilian M; Concordet, Jean-Paul JP
Publication Date: 2016-05-20

Variant appearance in text: DMD: Q926A
PubMed Link: 27210042
Variant Present in the following documents:
  • Main text
View BVdb publication page